Malgorzata Bartler - Alerislife Deputy CEO, Vice Chairman of the Management Board
| ALRDelisted Stock | USD 1.32 0.00 0.00% |
Chairman
Ms. Malgorzata Bartler was Deputy Chief Executive Officer and Vice Chairman of the Management Board of Alior Bank S.A. since October 14, 2015. She has over 20 years of experience in developing strategy and human resources management systems, gained in Polish and international companies in the following sectors banking, telecommunications, brewery, entertainment and fuel. Since 2014, Ms. Bartler was Human Resources Director at Alior Bank. In the years 20082014 she was Human Resources Director of P4 operator of the Play mobile network. Previously, she held the position of Human Resources Manager at Zywiec Group and Multikino S.A. Her professional career started at Shell, where she worked in the years 19941998. She graduated the Faculty of Management at Uniwersytet Warszawski and completed postgraduate studies in Human Resources Management at Szkola Glowna Handlowa w Warszawie. since 2015.
| Tenure | 9 years |
| Phone | 617 796 8387 |
| Web | https://www.alerislife.com |
Alerislife Management Efficiency
The company has Return on Asset of (0.0497) % which means that on every $100 spent on assets, it lost $0.0497. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.2183) %, meaning that it generated no profit with money invested by stockholders. Alerislife's management efficiency ratios could be used to measure how well Alerislife manages its routine affairs as well as how well it operates its assets and liabilities.The company has 9.41 M in debt with debt to equity (D/E) ratio of 0.48, which is OK given its current industry classification. Alerislife has a current ratio of 1.66, which is typical for the industry and considered as normal. Debt can assist Alerislife until it has trouble settling it off, either with new capital or with free cash flow. So, Alerislife's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Alerislife sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Alerislife to invest in growth at high rates of return. When we think about Alerislife's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 7 records | CHAIRMAN Age | ||
| Hilton Schlosberg | Monster Beverage Corp | 71 | |
| Rodney Sacks | Monster Beverage Corp | 67 | |
| Javier Ferran | Diageo PLC ADR | 63 | |
| Franz Humer | Diageo PLC ADR | 69 | |
| Michael Pruitt | Fresh Grapes LLC | 63 | |
| Paul Rayner | Treasury Wine Estates | 63 | |
| James Herbert | Neogen | 77 | |
Management Performance
| Return On Equity | -0.22 | |||
| Return On Asset | -0.0497 |
Alerislife Leadership Team
Elected by the shareholders, the Alerislife's board of directors comprises two types of representatives: Alerislife inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alerislife. The board's role is to monitor Alerislife's management team and ensure that shareholders' interests are well served. Alerislife's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alerislife's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Juliet Cunningham, VP of Investor Relations | ||
| Malgorzata Bartler, Deputy CEO, Vice Chairman of the Management Board | ||
| Sylwester Grzebinoga, Vice Chairman of the Management Board | ||
| Piotr Bystrzanowski, Head of Investor Relations | ||
| Jeffrey Leer, Pres CEO | ||
| Marcin Eckert, Member of the Supervisory Board | ||
| John Quelch, Independent Director | ||
| Dariusz Gatarek, Independent Member of the Supervisory Board | ||
| Michal Chyczewski, Vice Chairman of the Management Board | ||
| Pawel Szymanski, Independent Member of the Supervisory Board | ||
| John Martin, Non-Executive Independent Director | ||
| Brian Sherman, Chairman of the Board | ||
| Slawomir Niemierka, Member of the Supervisory Board | ||
| Philip Benjamson, VP COO | ||
| Krzysztof Czuba, Deputy CEO, Vice Chairman of the Management Board | ||
| Jennifer Clark, S MD | ||
| Neville Miles, Independent Non-Executive Director | ||
| Malgorzata IwaniczDrozdowska, Independent Vice Chairman of the Supervisory Board | ||
| Katarzyna Sulkowska, Deputy CEO, Vice Chairman of the Management Board | ||
| Marcin Jaszczuk, Vice Chairman of the Management Board | ||
| Joanna Krzyzanowska, Deputy CEO, Vice Chairman of the Management Board | ||
| Agata Strzelecka, Vice Chairman of the Management Board | ||
| Stephen Geiger, VP Officer | ||
| Vijay Moses, Sr Counsel | ||
| Gil Orski, Company Secretary | ||
| Ellen Chiniara, Vice President General Counsel, Secretary | ||
| Gregg Powers, Independent Director | ||
| Celina Waleskiewicz, Vice Chairman of the Management Board | ||
| Artur Kucharski, Independent Member of the Supervisory Board | ||
| Marek Szczesniak, Vice Chairman of the Management Board | ||
| Carol Goldberg, Independent Director | ||
| Hakan Bjorklund, Independent Director | ||
| Mateusz Poznanski, Vice Chairman of the Management Board | ||
| Mark Gladwell, Sr. VP of Global Operations | ||
| Filip Gorczyca, Vice Chairman of the Management Board | ||
| Heather Pereira, Treasurer VP | ||
| John Bridgen, Senior Vice President - Business Development | ||
| Mikolaj Handschke, Independent Member of the Supervisory Board | ||
| Seweryn Kowalczyk, Vice Chairman of the Management Board | ||
| Melissa Guerdan, Vice President-Global Quality Assurance | ||
| Tomasz Bilous, Vice Chairman of the Management Board | ||
| Renuka Uppaluri, Senior Vice President - Global Research and Development | ||
| James Kotarski, VP Officer | ||
| Adam Portnoy, Chairman MD | ||
| Namal Nawana, CEO and President and Director | ||
| Timothy Bonang, VP Relations | ||
| Tomasz Kulik, Chairman of the Supervisory Board | ||
| Stephen MacMillan, Independent Director | ||
| Brian Markison, Independent Director | ||
| Wojciech Sobieraj, Chairman of the Management Board, CEO | ||
| Maciej Surdyk, Vice Chairman of the Management Board | ||
| Susan Dooley, VP Marketing | ||
| Barry Sechos, Director | ||
| Barbara Smalska, Deputy CEO, Vice Chairman of the Management Board | ||
| James Roosevelt, Independent Director | ||
| Jonathan Wygant, Chief Accounting Officer | ||
| Sanjay Malkani, Global President of Toxicology | ||
| Maciej Rapkiewicz, Member of the Supervisory Board | ||
| James Hinrichs, CFO and Executive VP | ||
| Robert Hargadon, Vice President - Global Culture and Performance | ||
| Krzysztof Bachta, Vice Chairman of the Management Board | ||
| Wojciech Myslecki, Member of the Supervisory Board | ||
| Thomas McKillop, Independent Director | ||
| Geoffrey Ginsburg, Director | ||
| Augustine Daniels, Executive Director | ||
| Daniella Cramp, Global President of Cardiometabolic Bus. Unit | ||
| David Sokulsky, CEO, Chief Investment Officer | ||
| Urszula KrzyzanowskaPiekos, Vice Chairman of the Management Board | ||
| Witold Skrok, Deputy CEO, Vice Chairman of the Management Board for Finance | ||
| Regina Benjamin, Independent Director | ||
| Dariusz Szwed, Vice Chairman of the Management Board | ||
| Avi Pelossof, Global President of Infectious Disease Bus. Unit | ||
| Carla Flakne, Chief Accounting Officer and VP | ||
| John Levy, Independent Director |
Alerislife Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Alerislife a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.22 | |||
| Return On Asset | -0.0497 | |||
| Profit Margin | (0.24) % | |||
| Operating Margin | (0.19) % | |||
| Current Valuation | 17.82 M | |||
| Shares Outstanding | 33.47 M | |||
| Shares Owned By Insiders | 41.00 % | |||
| Shares Owned By Institutions | 18.80 % | |||
| Number Of Shares Shorted | 66.54 K | |||
| Price To Earning | (16.02) X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Alerislife in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Alerislife's short interest history, or implied volatility extrapolated from Alerislife options trading.
Pair Trading with Alerislife
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alerislife position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alerislife will appreciate offsetting losses from the drop in the long position's value.Moving together with Alerislife Stock
| 0.67 | MSFT | Microsoft Earnings Call This Week | PairCorr |
| 0.88 | NVDA | NVIDIA Financial Report 22nd of May 2024 | PairCorr |
| 0.74 | AMZN | Amazon Inc Earnings Call This Week | PairCorr |
Moving against Alerislife Stock
| 0.9 | AAPL | Apple Inc Report 2nd of May 2024 | PairCorr |
| 0.81 | BA | Boeing Earnings Call This Week | PairCorr |
| 0.66 | MCD | McDonalds Earnings Call This Week | PairCorr |
| 0.46 | INTC | Intel Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Alerislife could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alerislife when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alerislife - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alerislife to buy it.
The correlation of Alerislife is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alerislife moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alerislife moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alerislife can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Alerislife Stock
If you are still planning to invest in Alerislife check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alerislife's history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |